- Home
- COSM vs BRTX Comparison
COSM vs BRTX Comparison
Compare COSM & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- BRTX
- Stock Information
- Founded
- COSM 2009
- BRTX 1997
- Country
- COSM United States
- BRTX United States
- Employees
- COSM N/A
- BRTX N/A
- Industry
- COSM Other Pharmaceuticals
- BRTX Managed Health Care
- Sector
- COSM Health Care
- BRTX Health Care
- Exchange
- COSM Nasdaq
- BRTX Nasdaq
- Market Cap
- COSM 12.3M
- BRTX 12.5M
- IPO Year
- COSM 2013
- BRTX N/A
- Fundamental
- Price
- COSM $0.80
- BRTX $1.50
- Analyst Decision
- COSM
- BRTX Strong Buy
- Analyst Count
- COSM 0
- BRTX 1
- Target Price
- COSM N/A
- BRTX $18.00
- AVG Volume (30 Days)
- COSM 1.5M
- BRTX 65.1K
- Earning Date
- COSM 08-18-2025
- BRTX 08-12-2025
- Dividend Yield
- COSM N/A
- BRTX N/A
- EPS Growth
- COSM N/A
- BRTX N/A
- EPS
- COSM N/A
- BRTX N/A
- Revenue
- COSM $53,554,457.00
- BRTX $391,000.00
- Revenue This Year
- COSM $28.14
- BRTX $216.71
- Revenue Next Year
- COSM N/A
- BRTX $60.63
- P/E Ratio
- COSM N/A
- BRTX N/A
- Revenue Growth
- COSM N/A
- BRTX 161.54
- 52 Week Low
- COSM $0.28
- BRTX $1.21
- 52 Week High
- COSM $1.58
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- COSM 56.06
- BRTX 46.89
- Support Level
- COSM $0.74
- BRTX $1.38
- Resistance Level
- COSM $1.28
- BRTX $1.50
- Average True Range (ATR)
- COSM 0.18
- BRTX 0.09
- MACD
- COSM -0.01
- BRTX 0.00
- Stochastic Oscillator
- COSM 36.02
- BRTX 40.00
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.